Newly Engineered IgM and IgG Cleaving Enzymes for AAV Gene Therapy
Conferences
Smith, T; Hull, JA; Fusco, RM; Blondel, L; Elmore, Z; Asokan, A
Published in: MOLECULAR THERAPY
May 1, 2023
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
May 1, 2023
Volume
31
Issue
4
Start / End Page
113 / 113
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
Citation
APA
Chicago
ICMJE
MLA
NLM
Smith, T., Hull, J. A., Fusco, R. M., Blondel, L., Elmore, Z., & Asokan, A. (2023). Newly Engineered IgM and IgG Cleaving Enzymes for AAV Gene Therapy. In MOLECULAR THERAPY (Vol. 31, pp. 113–113).
Smith, Timothy, Joshua A. Hull, Robert M. Fusco, Leo Blondel, Zachary Elmore, and Aravind Asokan. “Newly Engineered IgM and IgG Cleaving Enzymes for AAV Gene Therapy.” In MOLECULAR THERAPY, 31:113–113, 2023.
Smith T, Hull JA, Fusco RM, Blondel L, Elmore Z, Asokan A. Newly Engineered IgM and IgG Cleaving Enzymes for AAV Gene Therapy. In: MOLECULAR THERAPY. 2023. p. 113–113.
Smith, Timothy, et al. “Newly Engineered IgM and IgG Cleaving Enzymes for AAV Gene Therapy.” MOLECULAR THERAPY, vol. 31, no. 4, 2023, pp. 113–113.
Smith T, Hull JA, Fusco RM, Blondel L, Elmore Z, Asokan A. Newly Engineered IgM and IgG Cleaving Enzymes for AAV Gene Therapy. MOLECULAR THERAPY. 2023. p. 113–113.
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
May 1, 2023
Volume
31
Issue
4
Start / End Page
113 / 113
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics